<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="6.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Cressey, Daniel</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Tiny traits cause big headaches</style></title><secondary-title><style face="normal" font="default" size="100%">Nature</style></secondary-title><short-title><style face="normal" font="default" size="100%">Nature</style></short-title></titles><dates><year><style  face="normal" font="default" size="100%">2010</style></year><pub-dates><date><style  face="normal" font="default" size="100%">9/2010</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">467</style></volume><pages><style face="normal" font="default" size="100%">264 - 265</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">The lack of understanding of the characteristics of many kinds of nanomaterials are delaying their use in medical applications. Some simple nanomedicines have been approved for use by regulating agencies in the U.S. and Europe, but smarter nanomedicines with more complex properties are currently under development. However, without proper characterization, progress on the medical use of nanoparticles, and its approval for use in humans, is likely to move slowly.</style></abstract><issue><style face="normal" font="default" size="100%">7313</style></issue></record></records></xml>